Studies have shown that SARS-CoV infection can downregulate ACE2 expression on cells and in pathological states resulting in elevated soluble ACE2 levels in blood, urine, and other body fluid [54]. This evidence concerns the gene ACE2 and severe acute respiratory syndrome.